--- Chain 14 for Question 88 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: A
Prompt Tokens (Usage): 168
Completion Tokens (Usage): 725
Reasoning Tokens (Counted): 551
Non-Reasoning Tokens (Counted): 172
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I have this question about rotavirus and some experiments done with GFP-tagged inner capsid proteins. Hmm, let me try to break it down.

So, the setup is that they tagged the inner capsid proteins with GFP and gave them to mice orally. Then they used in vivo imaging and saw some fluorescence destroyed by stomach acid, others got stuck in intestinal mucus before reaching secondary lymphoid organs. But some made it to the Peyer patches, and when they isolated proliferating cells there, they saw high variability in the variable heavy chain genes. The question is about which process is happening.

Wait, I remember that Peyer patches are part of the gut-associated lymphoid tissue (GALT) and are sites where immune responses are initiated, especially for things that are ingested or enter through the gut. So when the rotavirus capsid proteins are given orally, they might be taken up by these patches.

Fluorescence being destroyed by stomach acid probably means some of the proteins didn't survive the acidic environment. Others got entangled in mucus, which might prevent them from getting into the lymphoid tissues. But some did reach the Peyer patches.

In the Peyer patches, the immune system, particularly B cells, would encounter these antigens. B cells that recognize the antigen via their B cell receptors (BCRs) would then get activated. Once activated, B cells can start proliferating and differentiating. 

The high variability in the variable heavy chain genes upon sequencing suggests that there's some process causing the genes to change. I'm trying to think about the immune processes. Somatic hypermutation comes to mind. Somatic hypermutation is where B cells undergo mutation in their variable regions during the immune response, leading to increased diversity of antibodies. This process happens after the initial antigen recognition, especially in secondary lymphoid organs like the Peyer patches.

The other options: Complement activation is more about marking pathogens for destruction, but that doesn't directly cause variability in the genes. Class switching is about changing the type of antibody (like from IgM to IgG), but that's not about the variable regions. VDJ recombination happens during the development of B cells in the bone marrow, when the variable, diversity, and joining segments are rearranged to form the initial BCR. But in this case, the B cells are already mature and are responding to an antigen, so it's not VDJ again.

So after the initial BCR binding, B cells undergo somatic hypermutation in the germinal centers of lymphoid tissues, leading to more diverse antibodies. This is why when they look at the variable heavy chains, there's high variability. So the process is somatic hypermutation.


--- Final Answer Content ---


The experiment involves tagging rotavirus inner capsid proteins with GFP and administering them to mice via oral gavage. Some fluorescence is lost due to stomach acid or entanglement in intestinal mucus, but some tagged proteins reach the Peyer patches, where they are taken up by immune cells. The high variability observed in the variable heavy chain genes of proliferating cells in the Peyer patches suggests a process that increases genetic diversity in the immune response.

Somatic hypermutation is a process where B cells mutate their variable heavy chain genes after antigen recognition, leading to increased diversity of antibodies. This occurs in secondary lymphoid tissues like Peyer patches and explains the observed variability. Other options, such as complement activation, class switching recombination, and VDJ recombination, do not account for the variability in the variable heavy chain genes in this context.

Answer: A

--- Full Content ---
Okay, so I have this question about rotavirus and some experiments done with GFP-tagged inner capsid proteins. Hmm, let me try to break it down.

So, the setup is that they tagged the inner capsid proteins with GFP and gave them to mice orally. Then they used in vivo imaging and saw some fluorescence destroyed by stomach acid, others got stuck in intestinal mucus before reaching secondary lymphoid organs. But some made it to the Peyer patches, and when they isolated proliferating cells there, they saw high variability in the variable heavy chain genes. The question is about which process is happening.

Wait, I remember that Peyer patches are part of the gut-associated lymphoid tissue (GALT) and are sites where immune responses are initiated, especially for things that are ingested or enter through the gut. So when the rotavirus capsid proteins are given orally, they might be taken up by these patches.

Fluorescence being destroyed by stomach acid probably means some of the proteins didn't survive the acidic environment. Others got entangled in mucus, which might prevent them from getting into the lymphoid tissues. But some did reach the Peyer patches.

In the Peyer patches, the immune system, particularly B cells, would encounter these antigens. B cells that recognize the antigen via their B cell receptors (BCRs) would then get activated. Once activated, B cells can start proliferating and differentiating. 

The high variability in the variable heavy chain genes upon sequencing suggests that there's some process causing the genes to change. I'm trying to think about the immune processes. Somatic hypermutation comes to mind. Somatic hypermutation is where B cells undergo mutation in their variable regions during the immune response, leading to increased diversity of antibodies. This process happens after the initial antigen recognition, especially in secondary lymphoid organs like the Peyer patches.

The other options: Complement activation is more about marking pathogens for destruction, but that doesn't directly cause variability in the genes. Class switching is about changing the type of antibody (like from IgM to IgG), but that's not about the variable regions. VDJ recombination happens during the development of B cells in the bone marrow, when the variable, diversity, and joining segments are rearranged to form the initial BCR. But in this case, the B cells are already mature and are responding to an antigen, so it's not VDJ again.

So after the initial BCR binding, B cells undergo somatic hypermutation in the germinal centers of lymphoid tissues, leading to more diverse antibodies. This is why when they look at the variable heavy chains, there's high variability. So the process is somatic hypermutation.


The experiment involves tagging rotavirus inner capsid proteins with GFP and administering them to mice via oral gavage. Some fluorescence is lost due to stomach acid or entanglement in intestinal mucus, but some tagged proteins reach the Peyer patches, where they are taken up by immune cells. The high variability observed in the variable heavy chain genes of proliferating cells in the Peyer patches suggests a process that increases genetic diversity in the immune response.

Somatic hypermutation is a process where B cells mutate their variable heavy chain genes after antigen recognition, leading to increased diversity of antibodies. This occurs in secondary lymphoid tissues like Peyer patches and explains the observed variability. Other options, such as complement activation, class switching recombination, and VDJ recombination, do not account for the variability in the variable heavy chain genes in this context.

Answer: A